Fulcrum Therapeutics Files Proxy Materials
Ticker: FULC · Form: DEFA14A · Filed: Apr 30, 2026 · CIK: 0001680581
| Field | Detail |
|---|---|
| Company | Fulcrum Therapeutics, Inc. (FULC) |
| Form Type | DEFA14A |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, corporate-actions
Related Tickers: FULC
TL;DR
FULC filed proxy docs 4/30/26. Standard stuff, watch for shareholder votes.
AI Summary
Fulcrum Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on April 30, 2026. This filing is related to the solicitation of proxies. The company is located at 26 Landsdowne Street, Cambridge, MA 02139.
Why It Matters
This filing indicates ongoing corporate actions and shareholder communication, which can impact investor decisions and company governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or strategic changes that would immediately impact risk.
Key Numbers
- 2026-04-30 — Filing Date (Date the DEFA14A was filed and accepted.)
Key Players & Entities
- Fulcrum Therapeutics, Inc. (company) — Filer of the DEFA14A
- 0001680581 (company) — CIK number for Fulcrum Therapeutics, Inc.
- 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 (company) — Mailing and Business Address for Fulcrum Therapeutics, Inc.
- 0001193125-26-197308 (dollar_amount) — SEC Accession Number for the filing
FAQ
What type of filing is this DEFA14A for Fulcrum Therapeutics?
This is a Definitive Additional Materials filing, used for soliciting proxies.
When was this filing made?
The filing date was April 30, 2026.
What is Fulcrum Therapeutics' CIK number?
Fulcrum Therapeutics' CIK number is 0001680581.
Where is Fulcrum Therapeutics located?
Fulcrum Therapeutics is located at 26 Landsdowne Street, Cambridge, MA 02139.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001193125-26-197308.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 30, 2026 regarding Fulcrum Therapeutics, Inc. (FULC).